BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19783887)

  • 1. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
    Shin MK; Kim TH; Ju K; Ha CY; Min HJ; Jung WT; Lee OJ
    Korean J Hepatol; 2009 Sep; 15(3):370-4. PubMed ID: 19783887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferon/ribavirin-associated sudden hearing loss in a patient with chronic hepatitis C in Brazil.
    Mendes-Corrêa MC; Bittar RS; Salmito N; Oiticica J
    Braz J Infect Dis; 2011; 15(1):87-9. PubMed ID: 21412597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment.
    Elloumi H; Houissa F; Hadj NB; Gargouri D; Romani M; Kharrat J; Ghorbel A
    World J Gastroenterol; 2007 Oct; 13(40):5411-2. PubMed ID: 17879419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.
    Piekarska A; Jozefowicz-Korczynska M; Wojcik K; Berkan E
    Int J Audiol; 2007 Jul; 46(7):345-50. PubMed ID: 17680465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient.
    Johnson K; Sargent LA; Galizio C; Ubogu EE
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1110-4. PubMed ID: 19047844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C.
    Atug O; Akin H; Yilmaz Y; Sari M; Tozun N
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):256. PubMed ID: 19565068
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.
    Formann E; Stauber R; Denk DM; Jessner W; Zollner G; Munda-Steindl P; Gangl A; Ferenci P
    Am J Gastroenterol; 2004 May; 99(5):873-7. PubMed ID: 15128353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
    Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible sudden hearing loss in a chronic hepatitis C patient who achieved a sustained response to antiviral re-treatment.
    Zampino R; Costa G; Barillari M; Adinolfi LE; Marrone A
    Infez Med; 2012 Jun; 20(2):117-9. PubMed ID: 22767311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
    Papastergiou V; Skorda L; Lisgos P; Karatapanis S
    Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.
    Antonini MG; Babudieri S; Maida I; Baiguera C; Zanini B; Fenu L; Dettori G; Manno D; Mura MS; Carosi G; Puoti M
    Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
    J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C.
    Casale M; Mazzarelli C; Vespasiani Gentilucci U; Potena M; Pappacena M; Faiella F; Galati G; Salvinelli F; Picardi A
    Int J Immunopathol Pharmacol; 2012; 25(2):551-6. PubMed ID: 22697091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
    Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
    J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
    Lee MY; Cho H; Kim YM; Lee JS
    Korean J Hepatol; 2006 Sep; 12(3):444-8. PubMed ID: 16998297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.
    Le V; Bader T; Fazili J
    Nat Clin Pract Gastroenterol Hepatol; 2009 Jan; 6(1):57-60. PubMed ID: 19029995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.